Indian Court Nixes Roche's Bid To Bar Generic Tarceva
Cipla received a boost on Wednesday when the High Court of Delhi reportedly refused to intercept the Indian generics maker's efforts to manufacture and market F. Hoffmann-La Roche Ltd.'s cancer drug...To view the full article, register now.
Already a subscriber? Click here to view full article